Ezetimibe (Zetia) Shown to Reduce Heart Attack and Stroke After Thirty Billion Dollars in Sales
Important findings from the IMPROVE-IT trial were presented at the American Heart Association meeting yesterday. They demonstrate for the first time that the cholesterol lowering drug ezetimibe (brand name Zetia)